Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial.

Autor: Acharya, Nisha R.1,2,3 (AUTHOR) nisha.acharya@ucsf.edu, Ebert, Caleb D.1 (AUTHOR), Kelly, Nicole K.1 (AUTHOR), Porco, Travis C.1,2,3 (AUTHOR), Ramanan, Athimalaipet V.4 (AUTHOR), Arnold, Benjamin F.1,2 (AUTHOR), the ADJUST Research Group (AUTHOR), Doan, Thuy (AUTHOR), Gonzales, John A. (AUTHOR), von Scheven, Emily (AUTHOR), Angeles-Han, Shelia T. (AUTHOR), Miraldi Utz, Virginia (AUTHOR), Vitale, Albert T. (AUTHOR), Hersh, Aimee O. (AUTHOR), Overbury, Rebecca S. (AUTHOR), Stahl, Erin D. (AUTHOR), Cooper, Ashley M. (AUTHOR), Lerman, Melissa A. (AUTHOR), Davidson, Stefanie L. (AUTHOR), Thorne, Jennifer E. (AUTHOR)
Zdroj: Trials. 10/27/2020, Vol. 21 Issue 1, p1-12. 12p. 1 Diagram, 1 Graph.
Databáze: Academic Search Ultimate